[시장보고서]세계의 일렉트로컴피텐트 세포 시장 : 용도별, 세포 유형별, 형질전환 효율별, 포장 형태별, 최종 사용자별, 지역별

세계의 일렉트로컴피텐트 세포 시장 : 용도별, 세포 유형별, 형질전환 효율별, 포장 형태별, 최종 사용자별, 지역별

Electrocompetent Cells Market, By Application, By Cell Type, By Transformation Efficiency, By Packaging Format, By End User, By Geography

상품코드 : 1741168

리서치사 : Coherent Market Insights

발행일 : 2025년 03월

페이지 정보 : 영문

라이선스 & 가격 (부가세 별도)

US $ 4,500

￦ 6,561,000

Unprintable PDF & Excel (Single User License)

PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 7,000

￦ 10,206,000

PDF & Excel (Multi User License - Up to 7 Users)

PDF & Excel 보고서를 동일 기업 최대 7명까지 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능하며, 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

US $ 10,000

￦ 14,580,000

PDF & Excel (Corporate User License)

PDF & Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

세계의 일렉트로컴피턴트 세포 시장은 2025년 25억 3,000만 달러로 추정되고, 2032년까지 50억 9,000만 달러에 이를 것으로 예측되며, 2025년부터 2032년까지 CAGR 10.5%를 보일 것으로 예측됩니다.

보고 범위		보고서 세부정보
기준연도	2024년	2025년 시장 규모	25억 3,000만 달러
실적 데이터	2020-2024년	예측 기간	2025-2032년
예측 기간: 2025-2032년 CAGR:	10.50%	2032년 가치 예측	50억 9,000만 달러

일렉트로컴피텐트 세포는 일렉트로포레이션(세포막에 일시적인 기공을 형성하는 전계에 세포를 노출시키는 프로세스를 포함)에 의해 DNA를 도입하기 위해 준비된 세균 세포입니다. 외래 DNA가 세포에 삽입되어 복제되어 삽입된 DNA의 카피가 만들어집니다. 또한 일렉트로컴피텐트 세포는 유전자 재조합 생물을 제작하는 유전자 공학에도 이용됩니다.

시장 역학:

분자 클로닝 연구의 연구 활동과 자금 제공 활동이 증가하고 있습니다. 컴피덴트 세포는 다양한 생명 공학 절차에서 매우 효율적이므로 컴피덴트 세포 수요를 높일 것으로 예측됩니다.

그러나, 확실한 기술 지식을 가진 숙련된 전문가의 필요성은 예측 기간 동안 세계의 일렉트로컴피턴트 세포 시장의 성장을 방해할 것으로 예상되는 주요 요인 중 하나입니다.

이 조사의 주요 특징

이 조사 보고서는 세계의 일렉트로컴피텐트 세포 시장을 상세하게 분석해 2024년을 기준연도로 한 예측기간 2025-2032년 시장 규모 및 복합연간 성장률(CAGR%)을 제공합니다.
또, 다양한 부문에 걸친 잠재적인 수익 기회를 밝혀, 이 시장의 매력적인 투자 제안의 매트릭스에 대해서 해설했습니다.
또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 발매 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채용하는 경쟁 전략 등에 관한 주요 고찰도 제공합니다.
기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략 등의 파라미터에 근거해, 세계의 일렉트로컴피텐트 세포 시장의 주요 기업을 프로파일 하고 있습니다.
이 보고서로부터의 통찰은 마케팅 담당자나 기업의 경영진이, 장래의 제품 발매, 유형, 시장 확대, 마케팅 전술에 관한 정보에 근거한 의사 결정을 실시하는 것을 가능하게 할 것입니다.
이 조사 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 참가자, 재무 분석가 등이 업계의 다양한 이해 관계자를 대상으로 합니다.
이해관계자는 세계의 일렉트로컴피텐트 세포 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정이 용이해집니다.

시장 역학
- 성장 촉진요인
분자 클론 연구에 대한 조사 활동과 자금 제공 활동 증가
유전자 치료에 대한 투자 증가
- 억제요인
숙련된 전문가의 부족
- 기회
재조합 DNA 기술의 진보
영향 분석
주요 하이라이트
규제 시나리오
제품 출시/승인
PEST 분석
PORTER 분석
합병과 인수 시나리오

제4장 일렉트로컴피텐트 세포 시장 - 코로나바이러스(COVID-19) 팬데믹의 영향

COVID-19 역학
공급측과 수요측의 분석
경제에 미치는 영향

제5장 일렉트로컴피텐트 세포 시장 : 용도별, 2020-2032년

클론
단백질 발현
돌연변이 유발
유전체 DNA 라이브러리 구축
항체 생산
고처리량 스크리닝
기타

제6장 일렉트로컴피텐트 세포 시장 : 세포 유형별, 2020-2032년

대장균(E. coli)
사카로미세스 세레비시에(S. cerevisiae)
고초균(B. subtilis)
슈도모나스 퓨티다(P. putida)
폐렴연쇄상구균(S. pneumoniae)
기타

제7장 일렉트로컴피텐트 세포 시장 : 형질전환 효율별, 2020-2032년

고효율 셀
초고효율 셀

제8장 일렉트로컴피텐트 세포 시장 : 포장 형태별, 2020-2032년

튜브
플레이트
커스텀 포맷

제9장 일렉트로컴피텐트 세포 시장 : 최종 사용자별, 2020-2032년

제약 및 생명 공학 기업
학술연구기관
계약연구기관(CRO)
기타

제10장 일렉트로컴피텐트 세포 시장 : 지역별, 2020-2032년

북미
미국
캐나다
유럽
독일
영국
스페인
프랑스
이탈리아
러시아
기타 유럽
아시아태평양
중국
인도
일본
호주
한국
ASEAN
기타 아시아태평양
라틴아메리카
브라질
아르헨티나
멕시코
기타 라틴아메리카
아프리카
GCC 국가
이스라엘
기타 중동
아프리카
남아프리카
북아프리카
중앙 아프리카

제11장 경쟁 구도

Thermo Fisher Scientific Inc.
Merck KGaA
Agilent Technologies, Inc.
QIAGEN NV
New England Biolabs, Inc.
GenScript Biotech Corporation
Lucigen Corporation
Takara Bio Inc.
Delphi Genetics SA
IBA GmbH
Scarab Genomics LLC
Zymo Research Corporation
Bioline GmbH(Meridian Bioscience)
SelectScience
Biosearch Technology

제12장 섹션

조사 방법
출판사에 대해

JHS

영문 목차

영문목차

Electrocompetent Cells Market is estimated to be valued at USD 2.53 Bn in 2025 and is expected to reach USD 5.09 Bn by 2032, growing at a compound annual growth rate (CAGR) of 10.5% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 2.53 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	10.50%	2032 Value Projection:	USD 5.09 Bn

Electrocompetent cells are bacterial cells that have been prepared for the uptake of DNA through electroporation, a process that involves exposing the cells to an electric field that creates temporary pores in the cell membranes. This allows foreign DNA to enter the cell, which can then be incorporated into the cell's own DNA. This technique is commonly used in molecular biology for cloning purposes, and the cells are often used in research and development in the biotechnology and pharmaceutical industries. electrocompetent cells have a wide range of applications, particularly in the field of biotechnology and genetic engineering. here are some of the key applications,.such as cloning, electrocompetent cells are often used in cloning experiments. The foreign DNA is inserted into the cells, which then replicate, producing many copies of the inserted DNA. They are used in the production of proteins. Moreover, electrocompetent cells are used in genetic engineering to create genetically modified organisms. This can be used in agriculture to create crops with desirable traits, or in medicine to create bacteria that produce therapeutic proteins.

Market Dynamics:

There is a rise in research activities and funding activities in molecular cloning studies. This in turn is expected to boost the demand for competent cells, as they are highly efficacious in various biotechnology procedures. This factor is expected to support the growth of the global electrocompetent cells market over the forecast period.

However, the need for skilled professionals with sound technical knowledge is one of the major factors expected to hamper growth of the global electrocompetent cells market over the forecast period.

Key features of the study:

This report provides in-depth analysis of the global electrocompetent cells market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global electrocompetent cells market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies, Inc., QIAGEN N.V., New England Biolabs, Inc., GenScript Biotech Corporation, Lucigen Corporation, Takara Bio Inc., Delphi Genetics S.A., IBA GmbH, Scarab Genomics LLC, Zymo Research Corporation, Bioline GmbH (Meridian Bioscience), SelectScience and Biosearch Technology.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global electrocompetent cells market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global electrocompetent cells market

Global Electrocompetent Cells Market Detailed Segmentation:

By Application:
- Cloning
- Protein Expression
- Mutagenesis
- Genomic DNA Library Construction
- Antibody Production
- High-Throughput Screening
- Others
By Cell Type
- Escherichia coli (E. coli)
- Saccharomyces cerevisiae (S. cerevisiae)
- Bacillus subtilis (B. subtilis)
- Pseudomonas putida (P. putida)
- Streptococcus pneumoniae (S. pneumoniae)
- Others
By Transformation Efficiency:
- High Efficiency Cells
- Ultra-High Efficiency Cells
By Packaging Format:
- Tubes
- Plates
- Custom Formats
By End User:
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
- Contract Research Organizations (CROs)
- Others
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Company Profiles:
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Agilent Technologies, Inc.
- QIAGEN N.V.
- New England Biolabs, Inc.
- GenScript Biotech Corporation
- Lucigen Corporation
- Takara Bio Inc.
- Delphi Genetics S.A.
- IBA GmbH
- Scarab Genomics LLC
- Zymo Research Corporation
- Bioline GmbH (Meridian Bioscience)
- SelectScience
- Biosearch Technology

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Electrocompetent Cells, By Application
- Market Electrocompetent Cells, By Cell Type
- Market Electrocompetent Cells, By Transformation Efficiency
- Market Electrocompetent Cells, By Packaging Format
- Market Electrocompetent Cells, By End User
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
Rise in research activities and funding activities in molecular cloning studies
Increasing investments in gene therapy
- Restraints
Lack of skilled professionals
- Opportunities
Advancements in recombinant DNA technology
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Electrocompetent Cells Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Electrocompetent Cells Market , By Application, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Cloning
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Protein Expression
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Mutagenesis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Genomic DNA Library Construction
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Antibody Production
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
High-Throughput Screening
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Electrocompetent Cells Market, By Cell Type, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2023and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Escherichia coli (E. coli)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Saccharomyces cerevisiae (S. cerevisiae)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Bacillus subtilis (B. subtilis)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Pseudomonas putida (P. putida)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Streptococcus pneumoniae (S. pneumoniae)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Electrocompetent Cells Market, By Transformation Efficiency, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2023and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
High Efficiency Cells
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Ultra-High Efficiency Cells
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

8. Electrocompetent Cells Market, By Packaging Format, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2023and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Tubes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Plates
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Custom Formats
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

9. Electrocompetent Cells Market, By End User, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2023and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Pharmaceutical and Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Contract Research Organizations (CROs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

10. Electrocompetent Cells Market, By Region, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, By Country, 2023and 2032 (%)
- Y-o-Y Growth Analysis, For Country 2021-2032
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Transformation Efficiency, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Packaging Format, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Transformation Efficiency, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Packaging Format, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Transformation Efficiency, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Packaging Format, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Transformation Efficiency, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Packaging Format, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
Brazil
Argentina
Mexico
Rest of Latin America
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Transformation Efficiency, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Packaging Format, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
GCC Countries
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Transformation Efficiency, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Packaging Format, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
South Africa
North Africa
Central Africa

11. Competitive Landscape

Thermo Fisher Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Merck KGaA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Agilent Technologies, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
QIAGEN N.V.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
New England Biolabs, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
GenScript Biotech Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Lucigen Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Takara Bio Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Delphi Genetics S.A.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
IBA GmbH
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Scarab Genomics LLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Zymo Research Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Bioline GmbH (Meridian Bioscience)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
SelectScience
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Biosearch Technology
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Analyst Views

12. Section

Research Methodology
About us